These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37150026)

  • 1. Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk.
    Lim HY; Lui B; Tacey M; Barit D; Patel SK; Donnan G; Nandurkar H; Burrell LM; Ho P
    Thromb Res; 2023 Jun; 226():127-135. PubMed ID: 37150026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?
    Lim HY; Lui B; Tacey M; Selan C; Donnan G; Burrell LM; Nandurkar H; Ho P
    J Thromb Thrombolysis; 2021 Aug; 52(2):610-619. PubMed ID: 33625645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global coagulation assays in hypercoagulable states.
    Lim HY; Donnan G; Nandurkar H; Ho P
    J Thromb Thrombolysis; 2022 Jul; 54(1):132-144. PubMed ID: 34997471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease.
    Abdelmaguid A; Roberts LN; Tugores L; Joslin JR; Hunt BJ; Parmar K; Nebres D; Naga SS; Khalil ES; Bramham K
    J Thromb Haemost; 2022 Apr; 20(4):845-856. PubMed ID: 35068080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global coagulation assays in patients with diabetes mellitus.
    Lim HY; Lui B; Tacey M; Kwok A; Varadarajan S; Donnan G; Nandurkar H; Ho P
    Res Pract Thromb Haemost; 2021 Oct; 5(7):e12611. PubMed ID: 34765860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation system in patients with chronic kidney disease: a prospective observational study.
    Huang MJ; Wei RB; Wang Y; Su TY; Di P; Li QP; Yang X; Li P; Chen XM
    BMJ Open; 2017 Jun; 7(5):e014294. PubMed ID: 28576889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood.
    Knappe S; Gorczyca ME; Jilma B; Derhaschnig U; Hartmann R; Palige M; Scheiflinger F; Dockal M
    Thromb Haemost; 2013 Mar; 109(3):450-7. PubMed ID: 23348798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia.
    Egan K; O'Connor H; Kevane B; Malone F; Lennon A; Al Zadjali A; Cooley S; Monteith C; Maguire P; Szklanna PB; Allen S; McCallion N; Ní Áinle F
    Thromb Haemost; 2017 Jul; 117(8):1549-1557. PubMed ID: 28569919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of global coagulation assays in myeloproliferative neoplasm.
    Lim HY; Ng C; Rigano J; Tacey M; Donnan G; Nandurkar H; Ho P
    Blood Coagul Fibrinolysis; 2018 Apr; 29(3):300-306. PubMed ID: 29538005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of global coagulation assays between normal controls and patients with thrombocytopenia.
    Lim HY; Leung P; Manitta V; Nandurkar H; Ho P
    Int J Lab Hematol; 2019 Apr; 41(2):184-191. PubMed ID: 30365212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study.
    O'Keefe D; Lim HY; Tham J; Ho P; Hui L
    Int J Lab Hematol; 2021 Jun; 43(3):458-467. PubMed ID: 33174330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thromboelastography-based assessment of coagulation function in patients with chronic kidney disease and the risk factors of hypercoagulability].
    Wu S; Yuan H; Zhou Y; Long Z; Peng Y; Peng F
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):556-561. PubMed ID: 32895144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis.
    Jeong JC; Kim JE; Ryu JW; Joo KW; Kim HK
    Thromb Res; 2013 Nov; 132(5):604-9. PubMed ID: 24060191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the thrombin generation profile in systemic lupus erythematosus.
    Kern A; Barabás E; Balog A; Burcsár S; Kiszelák M; Vásárhelyi B
    Physiol Int; 2017 Mar; 104(1):35-41. PubMed ID: 28361572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent.
    Reddel CJ; Allen JD; Ehteda A; Taylor R; Chen VM; Curnow JL; Kritharides L; Robertson G
    J Thromb Haemost; 2017 Mar; 15(3):477-486. PubMed ID: 28058802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
    Erem C; Nuhoglu I; Yilmaz M; Kocak M; Demirel A; Ucuncu O; Onder Ersoz H
    J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RELATIONSHIP BETWEEN PRE- AND POST-THROMBOSIS FACTORS IN PATIENTS WITH STAGE VD CKD TREATED BY LONG-TERM HEMODIALYSIS.
    Storozhuk OB; Shevchuk SV; Storozhuk LO; Dovgalyuk TV; Storozhuk BG
    Wiad Lek; 2021; 74(3 cz 1):471-474. PubMed ID: 33813452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
    Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
    Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay.
    Curnow JL; Morel-Kopp MC; Roddie C; Aboud M; Ward CM
    J Thromb Haemost; 2007 Mar; 5(3):528-34. PubMed ID: 17166248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.
    Fernández-Bello I; López-Longo FJ; Arias-Salgado EG; Jiménez-Yuste V; Butta NV
    Orphanet J Rare Dis; 2013 May; 8():81. PubMed ID: 23711081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.